🕒 Thursday 12 June 2025 Thu, 12 June 2025

Accent Group reports a modest decline in like-for-like sales and margin compression in the second half of FY25, setting full-year EBIT guidance between $108 million and $111 million.

Challenger Limited has welcomed APRA’s consultation on new capital settings for annuity products, highlighting the potential for regulatory reforms to boost innovation and growth in Australia’s retirement income sector.

PointsBet Holdings has secured Foreign Investment Review Board approval for MIXI Australia's proposed full acquisition, marking a key regulatory milestone in the takeover process.

Harmoney’s founder Neil Roberts has sold 3.6 million shares, reducing his stake to 15%, as he transitions from Chief Strategy Officer to a non-executive director role.

BetMakers Technology Group has successfully raised $11.5 million through a share placement aimed at repaying debt and funding strategic growth initiatives, including a potential acquisition in Nevada.

Hazel Group Limited has temporarily paused trading of its securities on the ASX, signaling an impending announcement that investors will want to watch closely.

Larvotto Resources has reported impressive high-grade gold and antimony intercepts from its ongoing diamond drilling at the Hillgrove Project in NSW, signaling a promising update to its resource base and mine planning.

Peninsula Energy has resolved outstanding claims with its EPC contractor and is advancing a reset plan for its Lance uranium project, including revised production guidance and funding strategies.

Aureka Limited has raised $3 million through a share placement to accelerate exploration and secure land access at its key gold projects in Victoria, signalling strong investor confidence in its growth strategy.

Hawsons Iron Ltd has been reinstated to ASX trading following an announcement of a proposed capital raising, signaling renewed investor interest.

Hawsons Iron Limited is raising up to $1 million through a discounted Share Purchase Plan to fund critical project development while continuing strategic investor discussions.

Ragusa Minerals has terminated its binding agreement with Geopolymer Industries due to unmet conditions, reaffirming its commitment to the Burracoppin rare earths project and exploring fresh opportunities.

Mesoblast reports positive FDA progress on accelerated approval for Revascor in ischemic heart failure and plans a pivotal trial to extend Ryoncil’s label to adults with graft versus host disease, while its US commercial launch outpaces expectations.

HITIQ has partnered exclusively with Shock Doctor to launch the PROTEQT instrumented mouthguard, aiming to transform concussion management worldwide. The company also initiates a $2.92 million rights issue to fuel this ambitious rollout.

EV Resources Limited has finalized its acquisition of a 70% interest in the Los Lirios Antimony Mine in Oaxaca, Mexico, marking a strategic move to bolster critical mineral supply in the Americas. The company is advancing ore testing and plans to develop processing capabilities aligned with local community priorities.

Island Pharmaceuticals has reported encouraging Phase 2a/b trial results for ISLA-101, demonstrating meaningful reductions in dengue viral load and symptoms in humans. The findings support further clinical development of this antiviral candidate.

Macquarie Group Limited has announced a quarterly ordinary dividend of AUD 1.7239 per CAP Note security, payable in September 2025, with partial franking and a total distribution rate of 6.84% per annum.

MPower Group has struck a deal to sell nearly all its renewable energy assets to Wollemi Energy Group for about $19 million, unlocking significant shareholder value and setting the stage for a strategic reset.

EVE Health Group has completed its acquisition of Nextract Pty Ltd, positioning itself to enter the lucrative erectile dysfunction and dysmenorrhea markets with innovative drug delivery technologies.

AGL Energy has confirmed it is reviewing its 20% stake in Tilt Renewables following recent media speculation, though no sale discussions are underway. The outcome remains uncertain as the company conducts preliminary assessments.

AnteoTech secures a significant purchase order from the Serum Institute of India, driving its Life Sciences unit toward a projected 130% sales increase in FY2025 despite some project delays.

BPH Global Ltd has completed its second seaweed sale under a strategic partnership in Indonesia, marking steady progress in its supply network expansion and operational execution.

JPMorgan Asset Management has announced the June 2025 distribution and provided detailed tax attribution estimates for its US 100Q Equity Premium Income Active ETF, highlighting key income components and withholding tax implications.

Kinetiko Energy has completed a $2.2 million placement, supported by directors and major shareholders, to advance its gas exploration and production testing in South Africa’s Mpumalanga Province. Initial production test results are expected in July 2025.